1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Patient characteristics (N = 30)
CharacteristicsData
Male, No. (%)25 (83.3)
Age (yr)71 ± 9
Degree of stenosis %83 ± 9
History
    Ischemic heart disease, No. (%)12 (40.0)
    Hypertension, No. (%)21 (70.0)
    Diabetes mellitus type 2, No. (%)12 (40.0)
    Hyperlipidemia, No. (%)16 (53.3)
    Smoking, No. (%)7 (23.3)
Medications
    Aspirin, No. (%)27 (90.0)
    Ticlopidine, No. (%)1 (3.0)
    Clopidogrel, No. (%)23 (76.7)
    Cilostazol, No. (%)8 (26.7)
    Statins, No. (%)19 (63.3)
    Calcium channel blockers, No. (%)7 (23.3)
    ARBs, No. (%)14 (46.7)
Laboratory parameters
    Total cholesterol (mg/dL)186 ± 31
    Triglycerides (mg/dL)145 ± 49
    HDL cholesterol (mg/dL)46 ± 11
    LDL cholesterol (mg/dL)112 ± 31
    C-reactive protein (mg/dL)0.21 ± 0.21
    Hemoglobin A1C (mg/dL)6.2 ± 1.1
  • 

    Note:—ARBs indicates angiotensin II receptor blockers.